‘New GSK’ Should Consider New CEO Too, Says Activist Investor

Claims Leadership Lacks Credibility

 
• By Andrew McConaghie

Elliott Advisors have said more pharma expertise on the board – including a possible new CEO – is the only way for GSK to restore investor confidence.

LONDON- JUNE, 2018: The GlaxoSmithKline headquarters building in Brentford, west London. A British global pharmaceuticals company.
Elliott Investors wants GSK to aim for more ambitious sales and profits targets - and tie-in executives' bonuses. • Source: Alamy

More from Business

More from Scrip